ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 9 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $316,000 | +35.0% | 2,872,372 | +192.1% | 0.00% | – |
Q2 2020 | $234,000 | +2027.3% | 983,512 | +3101.0% | 0.00% | – |
Q3 2019 | $11,000 | -88.2% | 30,725 | -92.4% | 0.00% | – |
Q2 2019 | $93,000 | -89.6% | 403,679 | -0.7% | 0.00% | -100.0% |
Q1 2018 | $895,000 | +639.7% | 406,593 | +562.9% | 0.00% | – |
Q4 2017 | $121,000 | – | 61,334 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cambridge Investment Research Advisors, Inc. | 12,254,080 | $1,349,000 | 0.01% |
SABBY MANAGEMENT, LLC | 470,548 | $52,000 | 0.01% |
jvl associates llc | 58,500 | $6,000 | 0.01% |
WINTON GROUP Ltd | 717,882 | $79,000 | 0.00% |
REILLY FINANCIAL ADVISORS, LLC | 172,031 | $19,000 | 0.00% |
THOROUGHBRED FINANCIAL SERVICES, LLC | 21,000 | $2,000 | 0.00% |
RETIREMENT INCOME SOLUTIONS, INC | 32,060 | $3,000,000 | 0.00% |
JANE STREET GROUP, LLC | 223,538 | $25,000 | 0.00% |
Sequoia Financial Advisors, LLC | 15,000 | $2,000 | 0.00% |
UBS Group AG | 105,639 | $12,000 | 0.00% |